Price Chart

DATE TIME TYPE PERIOD REPORTED
EPS
ESTIMATED
EPS
SURPRISE
11/02/2022* -- Results Q3 2022 -- 1.44 --
11/02/2022* 17:00 EST Earnings Call Q3 2022 -- -- --
08/04/2022 -- Results Q2 2022 2.32 2.01 15.49%
08/04/2022 08:00 EST Earnings Call Q2 2022 -- -- --
05/03/2022 -- Results Q1 2022 2.41 2.12 13.46%
05/03/2022 17:00 EST Earnings Call Q1 2022 -- -- --
02/01/2022 -- Results Q4 2021 2.56 2.33 9.97%
02/01/2022 17:00 EST Earnings Call Q4 2021 -- -- --
*Estimated Date/Time

Earnings

Next Report Date 11/02/2022 (est.)
EPS Estimate Upgrade
Last Actual EPS Upgrade

Loading chart...
Last Report Date 08/04/2022
Beat/Miss Upgrade
Return Since 3.24%
Last FQE 06/30/2022
Next FQE 09/30/2022

Profile

Edit
PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
URL https://www.perkinelmer.com
Investor Relations URL https://www.perkinelmer.com/corporate/investors
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Growth
Next Earnings Release Nov. 02, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date Oct. 20, 2022
Last Ex-Dividend Date Jul. 21, 2022

Dividends

Dividend Per Share (TTM) 0.28
2017
2018
2019
2020
2021
No data available
 
6.00%
4.00%
2.00%
 
Yield to Market 0.1392
Yield to Sector 0.1007
Yield to Industry 0.5282
Last Dividend Amt. 0.07
Dividend Frequency Quarterly
Last Ex-Dividend Date Jul. 21, 2022
Yield (TTM) 0.18%
Forward Yield 0.18%
Payout Ratio 5.09%
Cash Payout Ratio 3.76%
Consistent Payer (5Y) Yes
Consistent Growth (5Y) Yes

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Total Returns Comparison

Edit comparables

Annual Total Returns Versus Peers

Edit comparables
Loading chart...
Name
2015
2016
2017
2018
2019
2020
2021
YTD
23.22%
-2.12%
40.85%
7.80%
24.01%
48.19%
40.37%
-21.36%
1.38%
11.96%
21.83%
-4.38%
31.49%
18.40%
28.71%
-9.34%
3.46%
10.15%
48.32%
1.67%
27.53%
39.77%
35.51%
-15.96%
23.70%
-12.16%
62.96%
-12.82%
71.85%
6.58%
55.36%
-26.23%
-13.25%
65.19%
41.97%
11.23%
62.03%
63.10%
52.64%
-38.91%
5.60%
51.60%
-66.50%
98.53%
87.59%
140.4%
-36.86%
-59.79%
As of August 12, 2022.

Profile

Edit
PerkinElmer provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments: diagnostics, which includes immunodiagnostics, reproductive health, and applied genomics, and discovery and analytical solutions, composed of life science, industrial, environmental, and food applications. PerkinElmer offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
URL https://www.perkinelmer.com
Investor Relations URL https://www.perkinelmer.com/corporate/investors
HQ State/Province Massachusetts
Sector Healthcare
Industry Diagnostics & Research
Equity Style Mid Cap/Growth
Next Earnings Release Nov. 02, 2022 (est.)
Last Earnings Release Aug. 04, 2022
Next Ex-Dividend Date Oct. 20, 2022
Last Ex-Dividend Date Jul. 21, 2022

Ownership

Insider Ownership Percentage Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Short Interest

Short Interest Upgrade
Percent of Shares Outstanding Short Upgrade
Jul '20
Nov '20
Mar '21
 
80.00%
40.00%
10.00%
 

Top Fund Holders

Symbol Dollars Invested % Weight
MJJ 2.653M USD 5.42%
THCX 1.353M USD 3.81%
OTCGX 396.99M USD 3.13%
BBHLX 62.89M USD 2.84%
PACLX 1.054B USD 2.31%
F00000Z1XG 244.76M USD 2.31%
ITCTX 176.04M USD 2.22%
SAMT 1.010M USD 1.94%
RPG 48.36M USD 1.88%
RYH 15.58M USD 1.66%
CAFFX 721.36M USD 1.10%
SCHM 51.15M USD 0.53%

Top Portfolio Holders

0 of 0

Other Resources

Whale Wisdom 13F Filings
Seeking Alpha Call Transcripts
Morningstar Insider Trading
Nasdaq Institutional Ownership
Nasdaq Option Chain
SEC SEC Filings
Twitter PKI Tweets